SCHEMBL6944136

SCHEMBL6944136

COCCCOc1cc(CCCCCCC(C(=O)NCCN2CCSCC2)(C(C)C)C(C)C)ccc1OC

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
REN P00797 15/20 0.55
SIGMAR1 Q99720 1/20 0.40
CYP3A4 P08684 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
F10 P00742 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6944173 0.99 REN (0.56) RENSIGMAR1CYP3A4TDP1F10
SCHEMBL6943202 0.91 REN (0.55) REN
Hydrochloric Acid SCHEMBL6942968 0.90 REN (0.56) REN
Hydrochloric Acid SCHEMBL6947328 0.87 REN (0.57) RENTDP1
SCHEMBL6944413 0.84 REN (0.48) REN
Hydrochloric Acid SCHEMBL6945622 0.84 REN (0.66) REN
Hydrochloric Acid SCHEMBL6947816 0.84 REN (0.49) REN
SCHEMBL6944430 0.83 REN (0.51) REN
SCHEMBL6947152 0.83 REN (0.51) REN
SCHEMBL6947040 0.83 REN (0.51) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003103653-A1 METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO claimed
WO-2003103653-A1 METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO disclosed